Cetera Investment Advisers’s iShares iBonds Dec 2025 Term Corporate ETF IBDQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-320,572
Closed -$8.08M 4777
2025
Q3
$8.08M Buy
320,572
+107,397
+50% +$2.7M 0.01% 1121
2025
Q2
$5.37M Sell
213,175
-9,864
-4% -$248K 0.01% 1145
2025
Q1
$5.61M Buy
223,039
+34,338
+18% +$862K 0.01% 1042
2024
Q4
$4.73M Buy
188,701
+25,399
+16% +$636K 0.01% 1062
2024
Q3
$4.1M Buy
163,302
+28,564
+21% +$713K 0.01% 1113
2024
Q2
$3.35M Sell
134,738
-7,986
-6% -$198K 0.01% 1220
2024
Q1
$3.54M Buy
142,724
+94,290
+195% +$2.34M 0.01% 1178
2023
Q4
$1.2M Buy
48,434
+10,824
+29% +$265K 0.01% 1003
2023
Q3
$917K Buy
37,610
+2,830
+8% +$69K 0.01% 1084
2023
Q2
$848K Buy
34,780
+23,891
+219% +$585K 0.01% 1132
2023
Q1
$267K Buy
10,889
+716
+7% +$17.5K ﹤0.01% 1771
2022
Q4
$247K Buy
+10,173
New +$246K ﹤0.01% 1777

Other funds holding IBDQ

Cetera Investment Advisers's IBDQ Position: Q4 2025 in Review

Cetera Investment Advisers sold out of iShares iBonds Dec 2025 Term Corporate ETF (IBDQ) in Q4 2025, closing a stake of 320,572 shares — an estimated $8.08M sold.

Cetera Investment Advisers first reported a position in IBDQ in Q4 2022 and held it in 12 quarters. The position peaked at $8.08M in Q3 2025. 3 funds tracked by Wall St. Rank hold IBDQ as of Q4 2025.

  • Cetera Investment Advisers reported no remaining iShares iBonds Dec 2025 Term Corporate ETF position as of Q4 2025 after selling out during the quarter.
  • Cetera Investment Advisers sold 320,572 iShares iBonds Dec 2025 Term Corporate ETF shares in Q4 2025, an estimated $8.08M.
  • Cetera Investment Advisers first reported a position in iShares iBonds Dec 2025 Term Corporate ETF in Q4 2022 and held it in 12 quarters.
  • Cetera Investment Advisers's iShares iBonds Dec 2025 Term Corporate ETF position peaked at $8.08M in Q3 2025.
  • 3 funds tracked by Wall St. Rank held iShares iBonds Dec 2025 Term Corporate ETF as of Q4 2025.

Based on Cetera Investment Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.